Abstract Archives of the RSNA, 2014
NRE175
Imaging Findings in Patients with Natalizumab-related Progressive Multifocal Leukoencephalopathy
Education Exhibits
Presented in 2014
Magna Cum Laude
Jerome Hodel, Presenter: Nothing to Disclose
Olivier Outteryck, Abstract Co-Author: Nothing to Disclose
Anne-Laure Bocher toledano MD, Abstract Co-Author: Nothing to Disclose
Helene Zephir, Abstract Co-Author: Nothing to Disclose
Celine Dubron, Abstract Co-Author: Nothing to Disclose
Marc Zins MD, Abstract Co-Author: Nothing to Disclose
Jean-Pierre Pruvo, Abstract Co-Author: Nothing to Disclose
Patrick Vermersch, Abstract Co-Author: Nothing to Disclose
Xavier Leclerc MD, PhD, Abstract Co-Author: Nothing to Disclose
The purpose of this exhibit is:
1. To describe the key imaging features of Natalizumab associated PML
2. To explain the utility of brain MRI in the early diagnosis
Summary:
Natalizumab, an effective treatment in multiple sclerosis, is associated with a risk of PML.
Brain MRI plays a major role for the early diagnosis of PML.
FLAIR is considered as a reference standard for detecting supratentorial PML lesions while T2w images improve the detection of infra-tentorial lesions and intralesional microcysts. Diffusion may suggest acute demyelination.
3D TSE MR sequences (Cube, GE; SPACE, Siemens; Brainview, Philips) may improve the detection of small PML lesions due to better image contrast and spatial resolution.
Specific imaging findings for early PML include:
- subcortical location involving U-fibers;
- ill defined border toward the white matter;
- increased signal intensity on both T2 and diffusion weighted images.
Key imaging features of natalizumab-associated PML are:
- subcortical U-fibers involvement,
- extension to adjacent gray matter,
- peripheral small punctuate hyperintense lesions and intra-lesional microcysts (« milky way appearance »)
1) MR protocol
2) Pictorial review: imaging features of natalizumab-associated PML
3) Pitfalls and mimics
4) Take home messages
http://abstract.rsna.org/uploads/2014/14010386/14010386_q3so.pdf
Hodel, J,
Outteryck, O,
Bocher toledano, A,
Zephir, H,
Dubron, C,
Zins, M,
Pruvo, J,
Vermersch, P,
Leclerc, X,
Imaging Findings in Patients with Natalizumab-related Progressive Multifocal Leukoencephalopathy. Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL.
http://archive.rsna.org/2014/14010386.html